Diabetes mellitus and blood glucose determinations: historical evolution, current technologies, and future perspectives

Authors

Keywords:

Diabetes Mellitus; Glucose; Continuous Glucose Monitoring; Glycated Hemoglobin; Glucose Tolerance Test

Abstract

Introduction: Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia due to defects in insulin secretion or action. It affects more than 415 million adults worldwide, with projections exceeding 642 million by 2040. Understanding blood glucose determination methods is essential for proper diagnosis and monitoring.

Objective: To describe diabetes mellitus as a chronic disease and the available means for its diagnosis and monitoring.

Methods: A narrative literature review was conducted through searches in PubMed, SciELO, and Scopus, using DeCS/MeSH descriptors. Articles from the last five years were prioritized, applying defined inclusion and exclusion criteria.

Development: The pathophysiology of T1DM involves autoimmune destruction of β-cells, while T2DM combines insulin resistance and progressive secretory failure. Glucose determination methods have evolved from qualitative urine tests to continuous monitors, non-invasive devices, and implantable systems. Glycemic variability emerges as an independent predictor of complications. The oral glucose tolerance test remains diagnostically relevant.

Conclusions: Diabetes constitutes a growing global health problem. Technological advances in glucose determination improve accuracy and quality of life. Prevention through diet and exercise remains the most cost-effective strategy. Local data from Cárdenas (11,801 patients) reinforce the need to update knowledge among professionals and the community.

Downloads

Download data is not yet available.

References

1. American Diabetes Association Professional Practice Committee. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2025. Diabetes Care. 2025;48(1 Suppl 1):S27-S49. doi:10.2337/dc25-S002.

2. World Health Organization. World Diabetes Day 2025. Geneva: WHO; [Internet] 2025 [citado 05/07/2026]. Disponible en: https://www.who.int/campaigns/world-diabetes-day/2025

3. American Diabetes Association Professional Practice Committee. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S20-S42. doi:10.2337/dc24-S002.

4. Senneville É, Albalawi Z, van Asten SA, et al. IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF/IDSA 2023). Diabetes Metab Res Rev. 2024;40(3):e3687. doi:10.1002/dmrr.3687

5. Singh A, Shadangi S, Gupta PK, Rana S. Type 2 Diabetes Mellitus: A Comprehensive Review of Pathophysiology, Comorbidities, and Emerging Therapies. Compr Physiol. 2025;15(1):e70003. doi:10.1002/cph4.70003

6. Esposito D, Boguszewski CL, Colao A, et al. Diabetes mellitus in patients with acromegaly: pathophysiology, clinical challenges and management. Nat Rev Endocrinol. 2024;20(9):541-552. doi:10.1038/s41574-024-00993-x

7. Lakhtakia R. The history of diabetes mellitus. Sultan Qaboos Univ Med J. 2013;13(3):368-370. doi:10.12816/0003257.

8. Mazur A. Why were "starvation diets" promoted for diabetes in the pre-insulin period?. Nutr J. 2011;10:23. doi:10.1186/1475-2891-10-23.

9. Magliano DJ, Boyko EJ; IDF Diabetes Atlas 10th edition scientific committee. IDF DIABETES ATLAS. 10th edition. Brussels: International Diabetes Federation; [Internet] 2021 [citado 05/07/2026]. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK581934/

10. Jamieson EL, Dimeski G, Flatman R, et al. Oral glucose tolerance test to diagnose gestational diabetes mellitus: Impact of variations in specimen handling. Clin Biochem. 2023;115:33-48. doi:10.1016/j.clinbiochem.2022.10.002

11. Marassi M, Morieri ML, Sanga V, Ceolotto G, Avogaro A, Fadini GP. The Elusive Nature of ABCC8-related Maturity-Onset Diabetes of the Young (ABCC8-MODY). A Review of the Literature and Case Discussion. Curr Diab Rep. 2024;24(9):197-206. doi:10.1007/s11892-024-01547-1

12. Petersmann A, Macdonald R, Nauck M. Disregarded Measurement Uncertainty Contributions and Their Magnitude in Measuring Plasma Glucose. J Diabetes Sci Technol. 2022;16(1):161-167. doi:10.1177/1932296820966353

13. Bomholt T, Kofod D, Nørgaard K, Rossing P, Feldt-Rasmussen B, Hornum M. Can the Use of Continuous Glucose Monitoring Improve Glycemic Control in Patients with Type 1 and 2 Diabetes Receiving Dialysis?. Nephron. 2023;147(2):91-96. doi:10.1159/000525676.

14. Lind N, Christensen MB, Hansen DL, Nørgaard K. Comparing Continuous Glucose Monitoring and Blood Glucose Monitoring in Adults With Inadequately Controlled, Insulin-Treated Type 2 Diabetes (Steno2tech Study): A 12-Month, Single-Center, Randomized Controlled Trial. Diabetes Care. 2024;47(5):881-889. doi:10.2337/dc23-2194

15. Gieroba B, Kryska A, Sroka-Bartnicka A. Type 2 diabetes mellitus - conventional therapies and future perspectives in innovative treatment. Biochem Biophys Rep. 2025;42:102037. Published 2025 May 2. doi:10.1016/j.bbrep.2025.102037.

16. Ajjan RA. The clinical importance of measuring glycaemic variability: Utilising new metrics to optimise glycaemic control. Diabetes Obes Metab. 2024;26 Suppl 7(Suppl 7):3-16. doi:10.1111/dom.16098.

17. Mo Y, Lu J, Zhou J. Glycemic variability: Measurement, target, impact on complications of diabetes and does it really matter?. J Diabetes Investig. 2024;15(1):5-14. doi:10.1111/jdi.14112.

18. Blonde L, Umpierrez GE, Reddy SS, et al. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. Endocr Pract. 2022;28(10):923-1049. doi:10.1016/j.eprac.2022.08.002

19. Waly Y, Hussain A, Al-Majmuei A, Alatoom M, Alaraibi AJ, Alaysereen A, Deen GR. Evolution of Biosensors and Current State-of-the-Art Applications in Diabetes Control. Biosensors. 2026 Jan 3;16(1):39. doi:10.3390/bios16010039.

20. Valenzano M, Bertolotti IC. Flash glucose monitoring versus oral glucose tolerance test: mind the gap. Acta Diabetol. 2023;60(4):591-593. doi:10.1007/s00592-022-02006-7.

21. Nauck MA, Müller TD. Incretin hormones and type 2 diabetes. Diabetologia. 2023;66(10):1780-1795. doi:10.1007/s00125-023-05956-x

22. Araki A. Individualized treatment of diabetes mellitus in older adults. Geriatr Gerontol Int. 2024;24(12):1257-1268. doi:10.1111/ggi.14979

23. Inaishi J, Kashiwagi K, Kinoshita S, et al. Associations between glycemic variability, sleep quality, and daily steps in subjects without diabetes using wearable devices. Metabol Open. 2023;20:100263. Published 2023 Nov 17. doi:10.1016/j.metop.2023.100263.

24. Harris S. Nutrition and diet in type 2 diabetes management. Br J Nurs. 2025;34(8):S11-S18. doi:10.12968/bjon.2024.0362.

25. Wilson LM, Herzig SJ, Marcantonio ER, Steinman MA, Schonberg MA, Wang BX, Hileman-Kaplan E, Anderson TS. Management of Diabetes and Hyperglycemia in the Hospital: A Systematic Review of Clinical Practice Guidelines. Diabetes Care. 2025 Apr 1;48(4):655-664. doi: 10.2337/dc24-2510.

Published

2026-08-15

How to Cite

1.
Rodríguez-Castillo MA, Méndez-Gómez HM, Polledo-Piñera Y. Diabetes mellitus and blood glucose determinations: historical evolution, current technologies, and future perspectives. MedEst [Internet]. 2026 Aug. 15 [cited 2026 Aug. 20];6:e565. Available from: https://revmedest.sld.cu/index.php/medest/article/view/565

Issue

Section

Narrative Review Article